RecruitingAortic Stenosis Treated With TAVIAortic Diseases
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR
Eligible age
50+ yrs
Accepts
All genders
Locations
7 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)
Sponsor: EnCompass Technologies, Inc.
Where it's recruiting
Source: ClinicalTrials.gov · NCT06689839 · last updated 2025-11-20